CORRECTION: Agilon Health Sees Q3 Sales $1.445B-$1.475B vs $1.415B Est

Benzinga Newsdesk www.benzinga.com Positive 78.9%

Neg 0% Neu 0% Pos 78.9%

Agilon Health (NYSE:AGL) sees Q3 sales of $1.445 billion-$1.475 billion vs $1.415 billion analyst estimate.

Comments

No comments yet. Be the first!